Variant report
Variant | nsv1332 |
---|---|
Chromosome Location | chr1:69894355-69905218 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:23)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:23 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr1:69898839-69899159 | IMR90 | lung: | n/a | chr1:69899008-69899017 chr1:69899006-69899017 |
2 | CEBPB | chr1:69896937-69896996 | HepG2 | liver: | n/a | n/a |
3 | CEBPB | chr1:69898171-69898387 | K562 | blood: | n/a | chr1:69898277-69898288 chr1:69898275-69898288 chr1:69898275-69898288 |
4 | CTCF | chr1:69905092-69905244 | K562 | blood: | n/a | n/a |
5 | FOS | chr1:69898779-69899117 | MCF10A-Er-Src | breast: | n/a | chr1:69898915-69898925 |
6 | FOS | chr1:69898785-69899196 | MCF10A-Er-Src | breast: | n/a | chr1:69898915-69898925 |
7 | FOS | chr1:69898888-69899100 | MCF10A-Er-Src | breast: | n/a | chr1:69898915-69898925 |
8 | GATA1 | chr1:69901229-69901984 | PBDE | blood: | n/a | chr1:69901577-69901586 chr1:69901579-69901586 chr1:69901579-69901586 chr1:69901579-69901586 |
9 | GATA2 | chr1:69904406-69904670 | K562 | blood: | n/a | n/a |
10 | GATA2 | chr1:69901427-69901726 | K562 | blood: | n/a | chr1:69901577-69901586 chr1:69901579-69901586 chr1:69901579-69901586 chr1:69901579-69901586 |
11 | JUND | chr1:69895371-69895580 | HepG2 | liver: | n/a | n/a |
12 | KAP1 | chr1:69895541-69895846 | K562 | blood: | n/a | n/a |
13 | MAFF | chr1:69900685-69900844 | HepG2 | liver: | n/a | n/a |
14 | MAFK | chr1:69900599-69900927 | HepG2 | liver: | n/a | n/a |
15 | MAFK | chr1:69900621-69900953 | HepG2 | liver: | n/a | n/a |
16 | MYC | chr1:69898857-69899117 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | NFYB | chr1:69899375-69899529 | GM12878 | blood: | n/a | n/a |
18 | POLR2A | chr1:69898428-69898628 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | TAL1 | chr1:69904346-69904699 | K562 | blood: | n/a | n/a |
20 | TAL1 | chr1:69901370-69901819 | K562 | blood: | n/a | n/a |
21 | TEAD4 | chr1:69901411-69901777 | K562 | blood: | n/a | n/a |
22 | TEAD4 | chr1:69904326-69904689 | K562 | blood: | n/a | n/a |
23 | USF1 | chr1:69896317-69896535 | K562 | blood: | n/a | n/a |
No data |
No data |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-LRRC7-3 | chr1:69900686-69901092 | XLOC_000243 |
2 | lnc-LRRC7-3 | chr1:69898938-69898988 | XLOC_000243 |
3 | lnc-LRRC7-3 | chr1:69898834-69898988 | NONHSAT003835 |
4 | lnc-LRRC7-3 | chr1:69900685-69901092 | NONHSAT003835 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000229639 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs371183095 | chr1:69895454-69895455 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs535314342 | chr1:69895462-69895463 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs193163082 | chr1:69895483-69895484 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs542943653 | chr1:69895520-69895521 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs562728531 | chr1:69895527-69895528 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs531622620 | chr1:69895548-69895549 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs556727063 | chr1:69895553-69895554 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs199769370 | chr1:69895577-69895578 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs200693768 | chr1:69895578-69895579 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs397715630 | chr1:69895580-69895581 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs113855707 | chr1:69895581-69895582 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs368213832 | chr1:69895582-69895583 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs184981113 | chr1:69895597-69895598 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs571397164 | chr1:69895648-69895649 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs527428459 | chr1:69895667-69895668 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs190220555 | chr1:69895670-69895671 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs140380057 | chr1:69895701-69895702 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs369346077 | chr1:69895794-69895795 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs535799383 | chr1:69895800-69895801 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs550236734 | chr1:69896318-69896319 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs398074030 | chr1:69896329-69896330 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs397715287 | chr1:69896330-69896331 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs117981508 | chr1:69896351-69896352 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs186607797 | chr1:69896383-69896384 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs549413975 | chr1:69896388-69896389 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs189391933 | chr1:69896406-69896407 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs539000264 | chr1:69896458-69896459 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs552804148 | chr1:69896496-69896497 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs566167844 | chr1:69896524-69896525 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs115024163 | chr1:69896943-69896944 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs74086378 | chr1:69896968-69896969 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs183386307 | chr1:69896969-69896970 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs529769257 | chr1:69897004-69897005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549450900 | chr1:69897006-69897007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs76657735 | chr1:69897012-69897013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs186148518 | chr1:69897024-69897025 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373978226 | chr1:69897058-69897059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs189771765 | chr1:69897089-69897090 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs34853469 | chr1:69897102-69897103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs542477130 | chr1:69897127-69897128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs535329775 | chr1:69897147-69897148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs148175581 | chr1:69897155-69897156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs182071451 | chr1:69897209-69897210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs576029784 | chr1:69897230-69897231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs188270321 | chr1:69897237-69897238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192795560 | chr1:69897260-69897261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs141979683 | chr1:69897333-69897334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539779500 | chr1:69897366-69897367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs561268003 | chr1:69897617-69897618 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs554378452 | chr1:69897619-69897620 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Melanoma | 17363583 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Ovarian cancer | 21720365 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17133270 | CNVD |
Type 2 diabetes | 21956041 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal cancer | 21851588 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Poland''s syndrome | 22110015 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 22429812 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:69897000-69897400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr1:69897600-69898000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr1:69898200-69899400 | Enhancers | NHEK | skin |
4 | chr1:69898600-69899400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr1:69899000-69899400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr1:69899000-69899400 | Enhancers | HMEC | breast |
7 | chr1:69899400-69906800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr1:69901200-69901400 | Enhancers | K562 | blood |
9 | chr1:69901400-69901800 | Flanking Active TSS | K562 | blood |
10 | chr1:69901800-69902400 | Enhancers | K562 | blood |
11 | chr1:69904000-69904400 | Enhancers | Fetal Kidney | kidney |